FDA Clears New Neurostimulation System for Chronic Pain
The US Food and Drug Administration has approved the Proclaim Plus spinal cord stimulation system with FlexBurst360 therapy, which provides personalized coverage at up to six pain points.
FDA Approvals
source https://www.medscape.com/viewarticle/979612?src=rss
FDA Approvals
source https://www.medscape.com/viewarticle/979612?src=rss
Comments
Post a Comment